Osteopontin is a therapeutic target that drives breast cancer recurrence.
Gu Y, Taifour T, Bui T, Zuo D, Pacis A, Poirier A, Attalla S, Fortier AM, Sanguin-Gendreau V, Pan TC, Papavasiliou V, Lin NU, Hughes ME, Smith K, Park M, Tremblay ML, Chodosh LA, Jeselsohn R, Muller WJ.
Gu Y, et al. Among authors: chodosh la.
Nat Commun. 2024 Oct 24;15(1):9174. doi: 10.1038/s41467-024-53023-9.
Nat Commun. 2024.
PMID: 39448577
Free PMC article.